Paris court fines Servier 2.7 million euros over weight-loss drug:BFM TV

© Reuters. Olivier Laureau, president of the Pharmaceutical group Servier, arrives to attend the trial of the Mediator drug case in Paris

PARIS (Reuters) – A Paris court on Monday found French drugmaker Servier guilty of manslaughter and deception over weight-loss pill Mediator, and fined it 2.7 million euros ($3.18 million), according to BFM Television.

France’s health ministry has said that at least 500 people died of heart valve problems in France because of exposure to the active ingredient in Mediator, a drug which was withdrawn from sale in 2009.

The court on Monday also fined France’s drug regulator ANSM 303,000 euros, BFM TV reported.

Servier’s press office did not immediately respond to a request from Reuters for comment. Contacted by Reuters, a spokeswoman for ANSM said she could not provide an immediate comment.

Servier has acknowledged in the past that Mediator had serious consequences for some patients and agreed to compensate some victims, but it also said it would fight inaccuracies and false statements

Once licensed as a diabetes treatment, Mediator was widely prescribed as an appetite suppressant to help people lose weight. Its active chemical substance is known as Benfluorex.

The drug was withdrawn from sale in Spain, Italy and the United States around a decade before it was pulled from the French market.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

READ  Trump takes executive action on economic relief

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.



Please enter your comment!
Please enter your name here